Recovering Your Investment: How to Take Action on the Regeneron Pharmaceuticals Inc. (REGN) Investigation – A Guide by Levi & Korsinsky

Levi & Korsinsky Investigates Regeneron Pharmaceuticals, Inc. for Possible Securities Violations Overview New York, NY / ACCESSWIRE / December 6, 2024 / Levi & Korsinsky has recently initiated an investigation into Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for potential breaches of federal securities laws. This investigation comes in the wake of Regeneron’s release of its third quarter…

Read More

Revolutionizing Seizure Treatment: Rapport Therapeutics Unveils Promising Data Linking Decreased RNS Levels to Significant Reductions in Clinical Seizures

Rapport Therapeutics Announces Breakthrough Findings in Epilepsy Treatment BOSTON and LOS ANGELES, Dec. 06, 2024 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) has recently unveiled groundbreaking revelations regarding the efficacy of their new drug, RAP-219, in the treatment of focal epilepsy. The company’s ongoing Phase 2a proof-of-concept trial has shown promising results, indicating a…

Read More

Revolutionizing Bolivia’s Economy: Attorneys Propose USDT Index to Boost Dollar Supply

Bolivian Attorneys Propose Tether’s USDT as Index Asset for Contracts Introduction In a groundbreaking move, Bolivian attorneys Iver von Borries and Javier Romero Mendizabal have put forth a proposal that could revolutionize the way commercial and civil contracts are structured. Their suggestion involves incorporating Tether’s USDT, the largest stablecoin in the cryptocurrency market, as an…

Read More

Discover the Latest Distribution Announcement from Templeton Emerging Markets Income Fund (TEI)

Templeton Emerging Markets Income Fund Announces Monthly Distribution Financial News FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–Templeton Emerging Markets Income Fund [NYSE: TEI] today announced a monthly distribution from net investment income of $0.0475 per share, payable on December 31, 2024, to shareholders of record on December 16, 2024 (Ex-Dividend Date: December 16, 2024). The Fund’s Board of…

Read More

Clever, Personable, and Unconventional: A Recap of Victoria’s Secret and Co.’s Q3 2024 Earnings Call

Welcome to the Victoria’s Secret & Co. Q3 2024 Earnings Conference Call Company Participants: Kevin Wynk – VP, External Financial Reporting & IR Hillary Super – CEO Tim Johnson – CFO Conference Call Participants: Simeon Siegel – BMO Capital Markets Brooke Roach – Goldman Sachs Alex Straton – Morgan Stanley Ike Boruchow – Wells Fargo…

Read More

Psyence Group Reaches Agreements with NASDAQ-Listed Associate Psyence Biomedical to Settle Outstanding Obligations

The Latest Update from Psyence Group Inc TORONTO, Dec. 06, 2024 Promising News for Investors Psyence Group Inc, a company known for its dedication to innovation and growth, has recently made a significant announcement. The company has entered into an addendum to debt-for-equity swap agreements with its associate, Psyence Biomedical Ltd, a NASDAQ-listed entity. This…

Read More